These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20975265)

  • 41. Successful reperfusion for acute ST elevation myocardial infarction is associated with a decrease in WBC count.
    Smit JJ; Ottervanger JP; Slingerland RJ; Suryapranata H; Hoorntje JC; Dambrink JH; Gosselink AT; de Boer MJ; van 't Hof AW
    J Lab Clin Med; 2006 Jun; 147(6):321-6. PubMed ID: 16750670
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Value of the SYNTAX score in patients treated by primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: The MI SYNTAXscore study.
    Magro M; Nauta S; Simsek C; Onuma Y; Garg S; van der Heide E; van der Giessen WJ; Boersma E; van Domburg RT; van Geuns RJ; Serruys PW
    Am Heart J; 2011 Apr; 161(4):771-81. PubMed ID: 21473978
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction of long-term outcome after primary percutaneous coronary intervention for acute anterior myocardial infarction.
    Wita K; Filipecki A; Szydło K; Turski M; Tabor Z; Wróbel W; Elzbieciak M; Lelek M; Bochenek T; Trusz-Gluza M
    Kardiol Pol; 2010 Apr; 68(4):393-400. PubMed ID: 20425697
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary intervention.
    Verouden NJ; Haeck JD; Kuijt WJ; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; van Straalen JP; Fischer J; Piek JJ; Tijssen JG; de Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1047-52. PubMed ID: 20381651
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Acute heart failure and early development of left ventricular dysfunction in patients with ST segment elevation acute myocardial infarction managed with primary percutaneous coronary intervention].
    Parenica J; Kala P; Jarkovský J; Poloczek M; Toman O; Goldbergová MP; Manousek J; Prymusová K; Kubková L; Tesák M; Elbl L; Cermáková Z; Spinar J
    Vnitr Lek; 2011 Jan; 57(1):43-51. PubMed ID: 21351662
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combining baseline clinical descriptors and real-time response to therapy: the incremental prognostic value of continuous ST-segment monitoring in acute myocardial infarction.
    Maas AC; Wyatt CM; Green CL; Wagner GS; Trollinger KM; Pope JE; Langer A; Armstrong PW; Califf RM; Simoons ML; Krucoff MW
    Am Heart J; 2004 Apr; 147(4):698-704. PubMed ID: 15077087
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early prognostic usefulness of C-reactive protein added to the Thrombolysis In Myocardial Infarction risk score in acute coronary syndromes.
    Foussas SG; Zairis MN; Lyras AG; Patsourakos NG; Tsirimpis VG; Katsaros K; Beldekos DJ; Handanis SM; Mytas DZ; Karidis KS; Tselioti PG; Prekates AA; Ambrose JA
    Am J Cardiol; 2005 Aug; 96(4):533-7. PubMed ID: 16098307
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between advanced Killip class at presentation and impaired myocardial perfusion among patients with ST-segment elevation myocardial infarction treated with primary angioplasty and adjunctive glycoprotein IIb-IIIa inhibitors.
    De Luca G; Gibson CM; Huber K; Zeymer U; Dudek D; Cutlip D; Bellandi F; Noc M; Emre A; Zorman S; Gabriel HM; Maioli M; Rakowski T; Gyöngyösi M; Van't Hof AW;
    Am Heart J; 2009 Sep; 158(3):416-21. PubMed ID: 19699865
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Repolarization parameters in patients with acute ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention with respect to predischarge ST-T pattern: a preliminary study.
    Szydło K; Wita K; Trusz-Gluza M; Zawada K; Piecuch A; Kulach A; Kucz E; Tyrka A; Kornacka I; Trams-Stawowska P; Pieda G
    Cardiol J; 2009; 16(1):52-6. PubMed ID: 19130416
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial).
    Marso SP; Miller T; Rutherford BD; Gibbons RJ; Qureshi M; Kalynych A; Turco M; Schultheiss HP; Mehran R; Krucoff MW; Lansky AJ; Stone GW
    Am J Cardiol; 2007 Jul; 100(2):206-10. PubMed ID: 17631071
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanism involved in the paradoxical effects of active smoking following primary angioplasty: a subanalysis of the protection of distal embolization in high-risk patients with acute myocardial infarction trial.
    Albertal M; Cura F; Escudero AG; Thierer J; Trivi M; Padilla LT; Belardi J;
    J Cardiovasc Med (Hagerstown); 2008 Aug; 9(8):810-2. PubMed ID: 18607246
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention.
    Hassan AK; Bergheanu SC; Hasan-Ali H; Liem SS; van der Laarse A; Wolterbeek R; Atsma DE; Schalij MJ; Jukema JW
    Am J Cardiol; 2009 Mar; 103(6):779-84. PubMed ID: 19268731
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Red cell distribution width as a novel prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction.
    Uyarel H; Ergelen M; Cicek G; Kaya MG; Ayhan E; Turkkan C; Yıldırım E; Kırbas V; Onturk ET; Erer HB; Yesilcimen K; Gibson CM
    Coron Artery Dis; 2011 May; 22(3):138-44. PubMed ID: 21233710
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mehran contrast-induced nephropathy risk score predicts short- and long-term clinical outcomes in patients with ST-elevation-myocardial infarction.
    Sgura FA; Bertelli L; Monopoli D; Leuzzi C; Guerri E; Spartà I; Politi L; Aprile A; Amato A; Rossi R; Biondi-Zoccai G; Sangiorgi GM; Modena MG
    Circ Cardiovasc Interv; 2010 Oct; 3(5):491-8. PubMed ID: 20923986
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of leukocyte count on mortality and bleeding in patients with myocardial infarction undergoing primary percutaneous coronary interventions: analysis from the Harmonizing Outcome with Revascularization and Stent in Acute Myocardial Infarction trial.
    Palmerini T; Mehran R; Dangas G; Nikolsky E; Witzenbichler B; Guagliumi G; Dudek D; Genereux P; Caixeta A; Rabbani L; Weisz G; Parise H; Fahy M; Xu K; Brodie B; Lansky A; Stone GW
    Circulation; 2011 Jun; 123(24):2829-37, 7 p following 2837. PubMed ID: 21632496
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Defining high-risk patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention: a comparison among different scoring systems and clinical definitions.
    Martinoni A; De Servi S; Politi A; Palmerini T; Musumeci G; Ettori F; Zanini R; Piccaluga E; Sangiorgi D; Repetto A; D'Urbano M; Castiglioni B; Fabbiocchi F; Onofri M; Lauria G; De Cesare N; Sangiorgi G; Lettieri C; Belli G; Poletti F; Pirelli S; Klugman S
    Int J Cardiol; 2012 May; 157(2):207-11. PubMed ID: 21236505
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic value of activated toll-like receptor-4 in monocytes following acute myocardial infarction.
    Sheu JJ; Chang LT; Chiang CH; Youssef AA; Wu CJ; Lee FY; Yip HK
    Int Heart J; 2008 Jan; 49(1):1-11. PubMed ID: 18360060
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Growth-differentiation factor 15 as predictor of mortality in acute reperfused ST-elevation myocardial infarction: insights from cardiovascular magnetic resonance.
    Eitel I; Blase P; Adams V; Hildebrand L; Desch S; Schuler G; Thiele H
    Heart; 2011 Apr; 97(8):632-40. PubMed ID: 21345844
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Value and level of galectin-3 in acute myocardial infarction patients undergoing primary percutaneous coronary intervention.
    Tsai TH; Sung PH; Chang LT; Sun CK; Yeh KH; Chung SY; Chua S; Chen YL; Wu CJ; Chang HW; Ko SF; Yip HK
    J Atheroscler Thromb; 2012; 19(12):1073-82. PubMed ID: 23037954
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interleukin-18 levels on admission are associated with mid-term adverse clinical events in patients with ST-segment elevation acute myocardial infarction undergoing percutaneous coronary intervention.
    Gao Y; Tong GX; Zhang XW; Leng JH; Jin JF; Wang NF; Yang JM
    Int Heart J; 2010 Mar; 51(2):75-81. PubMed ID: 20379038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.